Tianda Pharmaceuticals Limited

SEHK:455 Stok Raporu

Piyasa değeri: HK$397.8m

Tianda Pharmaceuticals Yönetim

Yönetim kriter kontrolleri 3/4

Tianda Pharmaceuticals' CEO is Alan Fang, appointed in Feb 2017, has a tenure of 7.75 years. directly owns 56.72% of the company’s shares, worth HK$225.62M. The average tenure of the management team and the board of directors is 7.8 years and 11.2 years respectively.

Anahtar bilgiler

Alan Fang

İcra Kurulu Başkanı

HK$60.0k

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi7.8yrs
CEO sahipliği56.7%
Yönetim ortalama görev süresi7.8yrs
Yönetim Kurulu ortalama görev süresi11.2yrs

Son yönetim güncellemeleri

Recent updates

Lacklustre Performance Is Driving Tianda Pharmaceuticals Limited's (HKG:455) 25% Price Drop

Oct 28
Lacklustre Performance Is Driving Tianda Pharmaceuticals Limited's (HKG:455) 25% Price Drop

Tianda Pharmaceuticals Limited (HKG:455) Investors Are Less Pessimistic Than Expected

Aug 16
Tianda Pharmaceuticals Limited (HKG:455) Investors Are Less Pessimistic Than Expected

Is Tianda Pharmaceuticals (HKG:455) Using Debt In A Risky Way?

Jun 20
Is Tianda Pharmaceuticals (HKG:455) Using Debt In A Risky Way?

There's Reason For Concern Over Tianda Pharmaceuticals Limited's (HKG:455) Massive 26% Price Jump

Mar 27
There's Reason For Concern Over Tianda Pharmaceuticals Limited's (HKG:455) Massive 26% Price Jump

Estimating The Fair Value Of Tianda Pharmaceuticals Limited (HKG:455)

Mar 02
Estimating The Fair Value Of Tianda Pharmaceuticals Limited (HKG:455)

Is Tianda Pharmaceuticals (HKG:455) Using Debt Sensibly?

May 23
Is Tianda Pharmaceuticals (HKG:455) Using Debt Sensibly?

Tianda Pharmaceuticals (HKG:455) Has Debt But No Earnings; Should You Worry?

Dec 06
Tianda Pharmaceuticals (HKG:455) Has Debt But No Earnings; Should You Worry?

Does Tianda Pharmaceuticals (HKG:455) Have A Healthy Balance Sheet?

Jan 11
Does Tianda Pharmaceuticals (HKG:455) Have A Healthy Balance Sheet?

Does Tianda Pharmaceuticals (HKG:455) Have A Healthy Balance Sheet?

Aug 05
Does Tianda Pharmaceuticals (HKG:455) Have A Healthy Balance Sheet?

Is Tianda Pharmaceuticals (HKG:455) Using Too Much Debt?

Dec 11
Is Tianda Pharmaceuticals (HKG:455) Using Too Much Debt?

CEO

Alan Fang (55 yo)

7.8yrs

Görev süresi

HK$60,000

Tazminat

Mr. Wen Quan Fang, also known as Alan, has been serves as Managing Director of Tianda Pharmaceuticals Limited since February 1, 2017. Mr. Fang has been Managing Director of Tianda Holdings Limited since Se...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Wen Quan Fang
Executive Chairman & MD7.8yrsHK$60.00k56.72%
HK$ 225.6m
Man Sang Lui
Executive Director11.2yrsHK$72.00kVeri yok
Man Yuk Wong
Financial Controller4.8yrsVeri yokVeri yok
Tai On Lo
Company Secretaryno dataVeri yokVeri yok

7.8yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim: 455's management team is seasoned and experienced (7.8 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Wen Quan Fang
Executive Chairman & MD21.1yrsHK$60.00k56.72%
HK$ 225.6m
Man Sang Lui
Executive Director11.2yrsHK$72.00kVeri yok
Sung Hong Chiu
Independent Non-Executive Director16.6yrsHK$72.00kVeri yok
Yat-Fai Lam
Independent Non-Executive Director20.2yrsHK$72.00kVeri yok
Tao Zhong
Non-Executive Director1.3yrsHK$25.00kVeri yok
Quanming Feng
Non-Executive Director8.7yrsVeri yokVeri yok
Yanfang Xian
Independent Non-executive Director1.4yrsHK$37.00kVeri yok

11.2yrs

Ortalama Görev Süresi

55yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 455's board of directors are seasoned and experienced ( 11.2 years average tenure).